Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126004341 | 12600434 | 1 | I | 2016 | 20160411 | 20160727 | 20160727 | PER | CA-BAYER-2016-069957 | BAYER | 91.00 | YR | E | F | Y | 0.00000 | 20160727 | OT | CA | CA |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126004341 | 12600434 | 1 | PS | ADEMPAS | RIOCIGUAT | 1 | UNK | 204819 | |||||||||||
| 126004341 | 12600434 | 2 | SS | ADEMPAS | RIOCIGUAT | 1 | Oral | 1.0 MG, TID | NOT PROVIDED | 204819 | 1 | MG | TID | ||||||
| 126004341 | 12600434 | 3 | SS | ADEMPAS | RIOCIGUAT | 1 | 1.5 MG, TID | 204819 | 1.5 | MG | TID | ||||||||
| 126004341 | 12600434 | 4 | SS | TYLENOL | ACETAMINOPHEN | 1 | 0 | ||||||||||||
| 126004341 | 12600434 | 5 | C | WARFARIN | WARFARIN | 1 | 0 | ||||||||||||
| 126004341 | 12600434 | 6 | C | SYMBICORT | BUDESONIDEFORMOTEROL FUMARATE DIHYDRATE | 1 | 0 | ||||||||||||
| 126004341 | 12600434 | 7 | C | VENTOLIN | ALBUTEROL SULFATE | 1 | 0 | ||||||||||||
| 126004341 | 12600434 | 8 | C | CIPRALEX | ESCITALOPRAM OXALATE | 1 | 0 | ||||||||||||
| 126004341 | 12600434 | 9 | C | CARBAMAZEPINE. | CARBAMAZEPINE | 1 | 0 | ||||||||||||
| 126004341 | 12600434 | 10 | C | HYDROCHLOROTHIAZIDE. | HYDROCHLOROTHIAZIDE | 1 | 0 | ||||||||||||
| 126004341 | 12600434 | 11 | C | CALCIUM | CALCIUM | 1 | 0 | ||||||||||||
| 126004341 | 12600434 | 12 | C | MAGNESIUM | MAGNESIUM | 1 | 0 | ||||||||||||
| 126004341 | 12600434 | 13 | C | HALIBUT | PACIFIC HALIBUT | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126004341 | 12600434 | 1 | Pulmonary hypertension |
| 126004341 | 12600434 | 2 | Pulmonary hypertension |
| 126004341 | 12600434 | 3 | Pulmonary hypertension |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126004341 | 12600434 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126004341 | 12600434 | Asthenia | |
| 126004341 | 12600434 | Blood pressure decreased | |
| 126004341 | 12600434 | Blood pressure diastolic decreased | |
| 126004341 | 12600434 | Chills | |
| 126004341 | 12600434 | Constipation | |
| 126004341 | 12600434 | Discomfort | |
| 126004341 | 12600434 | Dizziness | |
| 126004341 | 12600434 | Heart rate increased | |
| 126004341 | 12600434 | Herpes zoster | |
| 126004341 | 12600434 | Incorrect dose administered | |
| 126004341 | 12600434 | Pain | |
| 126004341 | 12600434 | Presyncope | |
| 126004341 | 12600434 | Product commingling | |
| 126004341 | 12600434 | Rash |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126004341 | 12600434 | 1 | 20141112 | 0 |